Navigation Links
The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs
Date:1/24/2013

PHOENIX, Jan. 24, 2013 /PRNewswire/ -- The Arizona Chapter of The Leukemia & Lymphoma Society and Avella Specialty Pharmacy announce they will present a day of discussion about the latest advancements, trends and management of oral chemotherapy medications. The free event will take place on Feb. 9, from 10:30 a.m. to 2:30 p.m., at SkySong, the ASU Scottsdale Innovation Center, 1475 N. Scottsdale Road, Scottsdale.

Local hematology/oncology community members will provide in-depth presentations on oral chemotherapy drugs including current trends, compliance and medication management. The event will feature two breakout sessions – one for nurses wherein they can earn complimentary CE credits and the other track for cancer patients and their families – as well as a town hall-style session featuring several local experts.

"More than 35 percent of the 400 cancer drugs in the pipeline are oral chemotherapy drugs. They clearly are the wave of the future," stated John Musil , Pharm.D., founder and CEO of Avella. "However, with so many breakthroughs, it's difficult for patients to stay on top of all of them. Our partnership with The Leukemia & Lymphoma Society aligns with our mission of optimizing patient health by educating healthcare professionals and patients on these advancements. Our hope is to provide similar discussions throughout the year as there is a growing need for this type of education."

Healthcare professionals will learn about current oral chemotherapy drug trends, compliance and best practices on how to provide adequate patient surveillance and support. Eric Sredzinski , Pharm.D., AAHIVE, Pharmacy Program Director, ADAP at Avella will lead this session. Continuing education credit will be provided to nurses.

The patient breakout session will focus on the importance of adhering to oral chem
'/>"/>

SOURCE Avella Specialty Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
2. Burlington Coat Factory Completes Another Record Year of Supporting The Leukemia & Lymphoma Society in its Quest to Beat Cancer
3. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
4. Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
5. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
6. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
7. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
8. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
9. Cell Therapeutics to Host Investor and Analyst Meeting to Discuss Targeted Agents in Myelofibrosis and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia on Sunday, June 3, 2012, in Chicago
10. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
11. Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for ... announced that it will release Second Quarter financial ... 2015. AcelRx management will host an investment-community conference ... Pacific Time) on Aug 3rd, 2015 to discuss ...
(Date:7/29/2015)... Calif. , July 29, 2015  Efforts to ... growth strategy of pharmaceutical firms in North ... The realization is that an effective working capital management ... pressures and patent cliffs. Big pharma companies expect to ... Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
(Date:7/29/2015)... July 29, 2015 Legal-Bay LLC, The Lawsuit Settlement ... Goodwin in the Southern District of West ... trial that was initially set to start in November. The ... but new plaintiffs were added and now it involves 39 ... 7 th , according to an article in Reuters. The ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3
... landscape for new pharmaceutical products has shifted dramatically, with ... changes facing launch teams. At the same time, the ... with the pharmaceutical industry facing pipeline deficits, patent expirations ... new launch environment, Best Practices, LLC has developed the ...
... 30, 2012  Molecular Detection Inc. (MDI), a company developing ... of infectious disease diagnosis, today announced it will release ... the 22nd European Congress of Clinical Microbiology and Infectious ... Panel has been further enhanced by increasing the number ...
Cached Medicine Technology:Excellence Services Program Helps Guide Pharmaceutical Industry Through the New Product Launch Landscape 2Molecular Detection Inc. Launches Improved Version of Detect-Ready® MRSA Panel at 2012 ECCMID Congress 2Molecular Detection Inc. Launches Improved Version of Detect-Ready® MRSA Panel at 2012 ECCMID Congress 3
(Date:7/29/2015)... ... ... privileged to announce that U.S. News & World Report has ranked the USC ... nation for 2015-2016. This marks the 21st consecutive year that the USC Eye Institute has ... to be included in the top 10 ophthalmology hospitals by U.S. News & World Report,” ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by a successful teaching ... W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine expert in Beverly ... need. , “We are thrilled for this opportunity to offer prolotherapy treatments for ...
(Date:7/29/2015)... ... 2015 , ... Stealth Therapeutics Inc. announced today that it ... Invisiport at Wheaton Franciscan Healthcare in Milwaukee, Wis. The Invisiport product line, which ... alternative to traditional chest ports and peripherally inserted central catheters (PICCs). It is ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... decision from the Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* ... research at their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the ...
(Date:7/29/2015)... ... 2015 , ... The Woodlands and Spring Fit Body Boot Camps have implemented ... causes each month. The new system will track each time a client uses social ... each facility, the boot camps will donate 20 cents to a selected charity. , ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3
... of a certain cell in the immune system may help ... the Program in Cellular and Molecular Medicine and the Immune ... 21 in Nature Immunology , they show, for the ... cells (DCs) capture flu viruses and show them to B-lymphocytes, ...
... provide target for future treatments, researchers say , MONDAY, ... variations linked with an increased risk for lung cancer ... research team analyzed DNA from more than 1,000 people ... smoked and found strong evidence that two variations in ...
... ... ... ... /PRNewswire/ - Haemacure Corporation (TSX:HAE) announces that it has obtained authorization from the Superior Court of the Province of Québec to sell its assets to Angiotech Pharmaceuticals, Inc., a ...
... MAYO Communications has been retained to promote the first MAMMOJAM 2010 set for Thursday, April 1, 2010 , at the newly opened Rise Club , 6801 W. Hollywood Blvd., ... , ... ... ...
... ... innovator in the live archiving space, MessageSolution is the first on-premise and SaaS archiving ... including Exchange, Domino GroupWise, file systems and SharePoint, delivering compliance archiving for all Unix/Linux-based ... ...
... ... surgery in Honolulu, Hawaii , is unveiling a new, interactive website geared toward educating web ... ... suffer from morbid obesity, weighing 80 pounds or more over the average for their size ...
Cached Medicine News:Health News:Poorly understood cell plays role in immunity against the flu 2Health News:Poorly understood cell plays role in immunity against the flu 3Health News:Court Authorizes Haemacure to Sell its Assets and Grants a Second Extension to Make a Proposal to its Creditors 2Health News:MAYO Communications Retained by MAMMOJAM 2010 Dr. Susan Love Research Foundation Event 2Health News:MAYO Communications Retained by MAMMOJAM 2010 Dr. Susan Love Research Foundation Event 3Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 2Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 3Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 4Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 5Health News:MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010 6Health News:Honolulu, Hawaii Bariatric Surgery Practice Launches New Website to Reach Out to Patients Fighting Morbid Obesity 2Health News:Honolulu, Hawaii Bariatric Surgery Practice Launches New Website to Reach Out to Patients Fighting Morbid Obesity 3
... Since its introduction to the market, the ... has proven itself as a highly efficient ... fields of urology and gastroenterology. The new ... been technically further developed and improved in ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
One piece, 100% fused silica construction offers low scatter and high efficiency...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
Medicine Products: